The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health•

Category: Regulatory & Policy

Ensuring standardised data collection for microbiome research, a sit down with DNA Genotek’s Heloise Breton and Austin Udocor
Pharma & Human Health

Ensuring standardised data collection for microbiome research, a sit down with DNA Genotek’s Heloise Breton and Austin Udocor

JUL 12, 2023
Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation
Infectious Disease & AMR

Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation

JUL 5, 2023
DNA Genotek enables development of microbiome-based clinical applications with OMNIgene™•GUT Dx – the first and only FDA-authorized fecal self-collection device
Editor's Choice

DNA Genotek enables development of microbiome-based clinical applications with OMNIgene™•GUT Dx – the first and only FDA-authorized fecal self-collection device

MAY 10, 2023
Recipharm will manufacture VOWST on behalf of Seres Therapeutics
Finance

Recipharm will manufacture VOWST on behalf of Seres Therapeutics

MAY 2, 2023
FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013
Clinical & Manufacturing

FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013

APR 28, 2023
Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™
Editor's Choice

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™

APR 27, 2023
Regulatory pathway needs to be developed to make the most of phages
Pharma & Human Health

Regulatory pathway needs to be developed to make the most of phages

FEB 16, 2023
Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection
Oncology

Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection

JAN 12, 2023
FDA Approves First Fecal Microbiota Product
Editor's Choice

FDA Approves First Fecal Microbiota Product

DEC 1, 2022
Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic
Editor's Choice

Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic

NOV 29, 2022
BiomeBank announces regulatory approval for donor derived microbiome drug
Finance

BiomeBank announces regulatory approval for donor derived microbiome drug

NOV 9, 2022